ETON PHARMACEUTICALS INC (ETON) Stock Price, Quote, News and Overview
NASDAQ:ETON - Nasdaq - US29772L1089 - Common Stock - Currency: USD
ETON Quote, Performance and Key Statistics
ETON PHARMACEUTICALS INC
NASDAQ:ETON (1/31/2025, 8:29:02 PM)
After market: 17.5 -0.18 (-1.02%)17.68
+0.36 (+2.08%)
The current stock price of ETON is 17.68 USD. In the past month the price increased by 32.73%. In the past year, price increased by 293.76%.
ETON Latest News, Press Releases and Analysis
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
Adds an additional commercial and strategic rare disease product to Eton’s portfolioGalzin is FDA-approved for the treatment of the ultra-rare metabolic...
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
Acquisition bolsters Eton’s commercial pediatric endocrinology portfolioProduct is now available through AnovoRx, a specialty pharmacy dedicated to serving...
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial
Clinical Trial Demonstrates Clinical and Statistical Improvement in Metabolic Control During Prolonged Fasting in PKU Patients - Results Expected to Promote Awareness and Adoption of PKU GOLIKE®
ETON Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 79.75 | 769.97B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 28.43 | 374.97B | ||
| JNJ | JOHNSON & JOHNSON | 15.23 | 366.32B | ||
| MRK | MERCK & CO. INC. | 16.61 | 249.98B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.57 | 219.43B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.04 | 209.36B | ||
| PFE | PFIZER INC | 10.28 | 150.29B | ||
| SNY | SANOFI-ADR | 14.85 | 136.24B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 50.38 | 119.56B | ||
| ZTS | ZOETIS INC | 29.67 | 77.10B | ||
| GSK | GSK PLC-SPON ADR | 8.5 | 71.96B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 22.32 | 42.45B |
Related stock screener links
About ETON
Company Profile
Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. The company is headquartered in Deer Park, Illinois and currently employs 30 full-time employees. The company went IPO on 2018-11-09. The firm is focused on developing and commercializing treatments for rare diseases. The firm has five commercial rare disease products: ALKINDI SPRINKLE, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The firm has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector. ALKINDI SPRINKLE is a granule hydrocortisone formulation designed to help provide accurate dosing for newborns and children with adrenal insufficiency. PKU GOLIKE is a next generation medical formula product engineered with the patent protected, pharmaceutical grade Physiomimic technology for the dietary management of phenylketonuria (PKU) under medical supervision. Carglumic Acid is used for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. Betaine Anhydrous is developed for the treatment of homocystinuria.
Company Info
ETON PHARMACEUTICALS INC
21925 W Field Pkwy Ste 235
Deer Park ILLINOIS 60010 US
CEO: Sean E. Brynjelsen
Employees: 30
Company Website: https://etonpharma.com/
Investor Relations: http://ir.etonpharma.com
Phone: 18477877361
ETON FAQ
What is the stock price of ETON?
The current stock price of ETON is 17.68 USD.
What is the symbol for ETON PHARMACEUTICALS INC stock?
The exchange symbol of ETON PHARMACEUTICALS INC is ETON and it is listed on the Nasdaq exchange.
On which exchange is ETON stock listed?
ETON stock is listed on the Nasdaq exchange.
Is ETON a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ETON, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ETON.
Does ETON stock pay dividends?
ETON does not pay a dividend.
What is the Price/Earnings (PE) ratio of ETON?
ETON does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.21).
What is the Short Interest ratio of ETON stock?
The outstanding short interest for ETON is 0.97% of its float.
ETON Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to ETON. When comparing the yearly performance of all stocks, ETON is one of the better performing stocks in the market, outperforming 98.64% of all stocks.
ETON Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to ETON. The financial health of ETON is average, but there are quite some concerns on its profitability.
ETON Financial Highlights
Over the last trailing twelve months ETON reported a non-GAAP Earnings per Share(EPS) of -0.21. The EPS increased by -400% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -15.29% | ||
| ROE | -34.3% | ||
| Debt/Equity | 0 |
ETON Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to ETON. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -129.5% and a revenue growth 18.53% for ETON